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Abstract
Haploinsufficiency for the HMG-box transcription factor SOX2 results in abnormalities of the
human ventral forebrain and its derivative structures. These defects include anophthalmia (absence
of eye), microphthalmia (small eye) and hypothalamic hamartoma (HH), an overgrowth of the
ventral hypothalamus. To determine how Sox2 deficiency affects the morphogenesis of the ventral
diencephalon and eye, we generated a Sox2 allelic series (Sox2IR, Sox2LP, and Sox2EGFP),
allowing for the generation of mice that express germline hypomorphic levels (<40%) of SOX2
protein and that faithfully recapitulate SOX2 haploinsufficient human phenotypes. We find that
Sox2 hypomorphism significantly disrupts the development of the posterior hypothalamus,
resulting in an ectopic protuberance of the prechordal floor, an upregulation of Shh signaling, and
abnormal hypothalamic patterning. In the anterior diencephalon, both the optic stalks and optic
cups (OC) of Sox2 hypomorphic (Sox2HYP) embryos are malformed. Furthermore, Sox2HYP eyes
exhibit a loss of neural potential and coloboma, a common phenotype in SOX2 haploinsufficient
humans that has not been described in a mouse model of SOX2 deficiency. These results establish
for the first time that germline Sox2 hypomorphism disrupts the morphogenesis and patterning of
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the hypothalamus, optic stalk, and the early OC, establishing a model of the development of the
abnormalities that are observed in SOX2 haploinsufficient humans.
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1. Introduction
SOX2 is a member of the SRY-related Box family of transcription factors. It plays a critical
role in embryonic development, maintains pluripotency and self-renewal potential in
embryonic stem cells, and was recently demonstrated to be able to cooperate with other
factors to induce pluripotency in a variety of somatic cell types (Avilion et al., 2003;
Takahashi et al., 2007; Lai et al., 2011). Consistent with the role of SOX2 in the
maintenance of neural potential and self-renewal, conditional ablation of Sox2 in retinal
progenitors shifts their fate from neural to ciliary epithelial, reducing their potential to
differentiate into post-mitotic neurons (Taranova et al., 2006; Matsushima et al., 2011). As a
key regulator of a wide array of morphogenetic processes, SOX2 is essential for the normal
development of the CNS, the sensory cells of the inner ear and eye, taste bud cells, the
division of early gut and respiratory structures, and branching and epithelial cell
differentiation in the lung (Kelberman et al., 2006; Okubo et al., 2006; Taranova et al., 2006;
Gontan et al., 2008; Domyan et al., 2011; Engelen et al., 2011). However, the precise role of
SOX2 in the morphogenesis of many of these tissues has not been examined in detail.
Specifically, there is a gap in our understanding of how reductions in SOX2 function
translate into the morphological defects that are observed in humans with SOX2
haploinsufficiency. This genetic disorder accounts for a significant percentage of cases of
anophthalmia, microphthalmia, and coloboma, the latter of which results from a failure of
the embryonic optic fissure to fuse (Fantes et al., 2003; Kelberman et al., 2006; Bakrania et
al., 2007; Schneider et al., 2009). Previous research using conditional ablation of Sox2 has
demonstrated its importance for maintaining the neural potential of retinal progenitors, but
the effects of germline Sox2 hypomorphism on the early stages of ocular development have
not been defined (Taranova et al., 2006; Matsushima et al., 2011). SOX2 haploinsufficient
humans also present with diencephalic abnormalities, such as hypothalamic hamartoma
(HH), a benign overgrowth of the hypothalamus that is associated with a variety of
developmental problems, cognitive deficiencies, and seizures (Freeman, 2003; Kelberman et
al., 2006; Wallace et al., 2008). SOX2 and GLI3 mutations are the only reported genetic
causes of human hamartomas; however, given that no animal model exists for HH, our
current understanding of how these defects develop is extremely limited from both a
morphological and molecular perspective.
Previous analyses of the role of SOX2 in the morphogenesis of the mammalian CNS have
primarily relied on the examination of (i) Sox2 heterozygous mice, (ii) mouse lines in which
Sox2 is ablated in a spatiotemporally-specific manner, or (iii) mouse lines with mutations
affecting Sox2 enhancers (Dong et al., 2002; Ferri et al., 2004; Kiernan et al., 2005;
Kelberman et al., 2006; Taranova et al., 2006; Miyagi et al., 2008; Matsushima et al., 2011).
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Each of these approaches is limited with respect to their ability to model human SOX2
haploinsufficiency. Sox2+/− mice do not typically exhibit ocular defects, which are almost
ubiquitous in SOX2 haploinsufficient humans, precluding the use of Sox2+/− mice as a
model of SOX2 haploinsufficiency (Avilion et al., 2003; Ellis et al., 2004; Kelberman et al.,
2006; Taranova et al., 2006; Schneider et al., 2009). Moreover, the vast majority of reported
human SOX2 haploinsufficiency cases result from mutations in the SOX2 open reading
frame, most likely resulting in systemic attenuation of SOX2 function. Therefore, models
that make use of restricted modification of Sox2 expression do not recapitulate the genetic
environment associated with human SOX2 haploinsufficiency (Schneider et al., 2009).
To determine how reduced SOX2 dosage impacts the development of the neural ectoderm
derivatives that are affected in SOX2 haploinsufficient humans, we generated a series of
knockin Sox2 hypomorphic (Sox2LP and Sox2IR) and null (Sox2EGFP) alleles. Sox2EGFP/LP
and Sox2EGFP/IR (collectively referred to as Sox2HYP) mice express less than 40% of wild
type SOX2 protein levels and exhibit variable anophthalmia and microphthalmia, similar to
SOX2 haploinsufficient humans (Ellis et al., 2004; Taranova et al., 2006). Sox2HYP mice
exhibit a global reduction in SOX2 levels, a genetic environment that mimics that of SOX2
haploinsufficient humans. Here, we present a detailed analysis of Sox2HYP mice and
ascertain the temporal onset of the ocular and diencephalic morphological defects that result
from reduced SOX2 dosages. We find that Sox2HYP embryos exhibit morphological and
molecular abnormalities of the posterior prechordal floor, including an upregulation of Shh
and a downregulation of Gli3. E10.5 Sox2HYP embryos exhibit morphological defects of the
optic stalk and optic cup (OC), and molecular patterning abnormalities in the retinal
primordium. Sox2HYP eyes exhibit decreased levels of Pax2 and are colobomic, a phenotype
that has not been described in a mouse model of Sox2 deficiency. Taken together, these
results (i) represent the first characterization of the molecular and morphological phenotype
of the SOX2 mutant hypothalamus, a region known to be affected in SOX2 haploinsufficient
humans; (ii) establish the morphological and molecular onset of the ocular defects observed
in Sox2HYP mice; and (iii) establish an animal model for SOX2 deficiency-related coloboma.
2. Materials and methods
2.1. Animals
The generation of the Sox2IR, Sox2LP, Sox2EGFP alleles has been previously described (Ellis
et al., 2004; Taranova et al., 2006). Sox2IR/+ and Sox2LP/+ females were bred to Sox2EGFP/+
stud males to generate Sox2EGFP/IR, Sox2EGFP/LP, Sox2+/LP, Sox2+/IR and Sox2+/+ embryos
(Taranova et al., 2006). No phenotypic differences were observed between Sox2+/+,
Sox2IR/+, or Sox2LP/+ embryos, and these embryos were considered controls (Sox2CONT).
Sox2EGFP/LP embryos were reported to express approximately 10% lower levels of SOX2
protein than Sox2-EGFP/IR embryos; however, no clear phenotypic differences were observed
between these genotypes with respect to any of the described phenotypes. Sox2EGFP/LP and
Sox2EGFP/IR embryos are therefore are collectively referred to as Sox2HYP. All of the
molecular and scanning electron microscopy (SEM) analyses were performed on a mixed
C57BL/6-CD1 (Jackson Laboratories) background. Sox2HYP mice on this background mice
display less severe but similar phenotypes to Sox2HYP C57BL/6 mice. Whole mount
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morphological analyses of E13-E14 embryos were performed on a C57BL/6 background.
All of the animal work was performed in accordance with University of North Carolina at
Chapel Hill DLAM and IACUC approval. The date of vaginal plug was considered E0.5,
and precise embryo stages were determined using established somite reference points (Chan
et al., 2004).
2.2. Genotyping protocols
Sox2 alleles were genotyped using the following primer sequences and protocols: for the
Sox2 wildtype allele, 5′-GCTCTGTTATTGGAATCAGGCTGC-3′ and 5′-
CTGCTCAGGGAAGGAGGGG-3′, (35 cycles of 15 s at 94 °C, 30 s at 55 °C, 30 s at 72
°C); for the Sox2IR allele, 5′-GGCTCTCCTCAAGCGTATTCAA-3′ and 5’-
TTGTAGTCGGGGATGCGGC-3’, (35 cycles of 15 s at 94 °C, 30 s at 58 °C, 45 at 72 °C);
for the Sox2LP allele, 5′-CAGCAGCCTCTGTTCCACATACAC-3′ and 5′-
CAACGCATTTCAGTTCCCCG-3′, (35 cycles of 15 s at 94 °C, 30 s at 55 °C, 30 at 72 °C).
The presence of the Sox2EGFP allele was determined visually using a UV fluorescent
microscope.
2.3. Tissue preparation for SEM analyses
The embryos were processed in a manner similar to that described in Sulik et al., 1994.
Briefly, the embryos were fixed in 2.5% glutaraldehyde, cut manually through the forebrain
at or near the level of the optic primordium, and post-fixed for 1–2 h in 2% osmium
tetroxide. The samples were then dehydrated in a graded ethanol series and critical point
dried using liquid CO2. The samples were then mounted on aluminum stubs, manually
cleaned of debris, coated with a gold–palladium sputter-coater, and imaged on a JEOL 6300
scanning electron microscope.
2.4. Tissue preparation for immunohistochemical and in situ hybridization analyses
The embryos were fixed at 4 °C in a solution of phosphate buffered saline (PBS) and 4%
paraformaldehyde for periods of 2 h to overnight, depending on the stage of the embryo.
Following three washes in PBS, the embryos were cryoprotected in a sucrose gradient (10%,
20%, and 30% sucrose in PBS) and mounted in Optimum Cutting Temperature mounting
medium (OCT, Tissue-Tek). For immunohistochemical (IHC) analyses, frontal 10 μm
sections were blocked in a solution of 1–4% heat-inactivated goat serum and 0.1% Triton
X-100 (Sigma). The sections were incubated with primary antibodies overnight at 4 °C and
with secondary antibodies for 1 h at room temperature. For in situ analyses, 20 μm frontal or
horizontal sections were incubated with digoxigenin (DIG)-labeled probes and visualized
using enzymatic detection, following the manufacturer’s protocol (Roche). The following
antibodies were used for this study: rabbit anti-PH3 (1:1000, Abcam), rabbit anti-cleaved
capase-3 (1:250, Cell Signaling), and Alexa Fluor 546-conjugated anti-rabbit (1:1000,
Molecular Probes). The following in situ hybridization probes were used for this study:
Nkx2.1 [Dr. A. Lamantia, (Shimamura et al., 1995)], Otx1 [Dr. J. P. Martinez-Barbera,
(Simeone et al., 1992)], Pax2 [Dr. J.P. Martinez-Barbera, (Sajedi et al., 2008)], Pax6 [Dr. A.
LaMantia, (Anchan et al., 1997)], Rax [Dr. C. Cepko, (Furukawa et al., 1997)], Shh (Dr. E.
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Tucker), Tbx3, [Dr. M. Pontecorvi, (Pontecorvi et al., 2008)], and Vax2 [Dr. G. Lemke, (Mui
et al., 2005)]. At least three Sox2CONT and Sox2HYP embryos were analyzed for each probe.
2.5. Measurements and statistics
All of the optic stalk length measurements were made relative to the head width of the
embryo at the optic level. E10.5 head-width measurements were made between the points on
the surface ectoderm where the maxillary process emerges, immediately ventral to the eye.
The optic stalk lengths were measured linearly. All of the distance measurements were made
in triplicate using ImageJ software and averaged. The Mendelian ratios were examined with
the two-tailed squared test using three degrees of freedom. The cell death and proliferation
analyses were performed by computing the ratio of positively stained cells to the total
number of cells in a predefined region. Cells were only considered PH3-positive if they were
located along the apical edge of the retina. Cells were considered positive for cleaved
caspase-3 if staining could be directly associated with a condensed or fragmented nucleus.
The results are reported as the mean ± the standard error of the mean. At least three
Sox2CONT and Sox2HYP embryos were analyzed for cell death and proliferation and for all in
situ gene expression analyses. Once the penetrance of the hypothalamic defect was
determined, the gene expression analyses were performed on severely affected embryos only
(see Fig. 2 legend).
2.6. Anatomic nomenclature
The anatomical features referred to below are defined as follows and are diagrammed in Fig.
S1. According to the revised prosomeric model of Puelles and Rubenstein, 2003 the
prechordal floor is defined as the ventral-most aspect of the diencephalon and
telencephalon, with a caudal limit at the posterior edge of the retromammillary area. The
mammillary area is defined as the region surrounding the mammillary body anlage, which is
located near the posterior limit of the prechordal floor. The mammillary pouch is defined as
the invagination of the prechordal floor within the mammillary area and was used as
amorphological landmark for the expression analyses (García-Calero et al., 2006). The
tuberal hypothalamus is defined as the region of the prechordal floor anterior to the
mammillary area and posterior to the infundibulum (Shimamura et al., 1995). The ciliary
margin of both E10.5 and E16.5 retinas is defined as the distal aspect of the retina.
3. Results
3.1. Sox2HYP embryos are recovered in Mendelian ratios and do not exhibit global
developmental delays
Sox2HYP embryos carry a Sox2EGFP null reporter allele and either the Sox2IR or Sox2LP
hypomorphic allele. When expressed in mice, these alleles have been shown to result in less
than 40% of wild-type SOX2 protein levels (Taranova et al., 2006). Given that SOX2 is
required for the survival of the peri-implantation embryo, we analyzed genotypic ratios at
different embryonic stages (E9.5–E18) to determine whether Sox2HYP embryos display
increased embryonic lethality. Sox2-HYP embryos are recovered at the expected Mendelian
ratio (Table S1). To determine whether overall development is delayed in Sox2HYP embryos,
somite counts for E9.5 and E10.5 litters were tabulated and found to be similar between
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Sox2CONT and Sox2HYP embryos (Table S1). These results indicate that (i) Sox2 deficiency
does not lead to embryonic lethality, and (ii) the morphological defects observed in Sox2HYP
mice are not the result of a developmental delay (See Table S1).
3.2 The diencephalic prechordal floor is laterally expanded in E10.5 Sox2HYP embryos
SOX2 haploinsufficient humans exhibit HH, an overgrowth of the posteroventral
diencephalon. Given the complex and dynamic morphology of the developing diencephalon,
we used SEM to analyze this region in E9.5 and E10.5 Sox2HYP embryos. The SEM data
revealed that the posterior prechordal floor is broader in Sox2HYP embryos as early as E9.5
(Fig. S1D vs. E and F). By E10.5, two evaginations are visible in the Sox2-CONT prechordal
floor; the infundibulum, which is the precursor of the posterior and infundibular lobes of the
pituitary, and the more posterior mammillary pouch (Fig. 1 and Fig. S2). SEM images of
E10.5 Sox2HYP embryos revealed that the infundibulum is broadened (Fig. 1D vs. E and F).
The infundibular widths were determined from measurements of histological sections, which
confirmed a statistically significant expansion of the infundibulum in Sox2HYP embryos
(Sox2CONT: 147.0 ± 3.7 μm, Sox2HYP: 183.8 ± 10.3 μm, p < 0.05, n = a minimum of 5 for
each group, Fig. S3). With respect to the mammillary pouch, Sox2CONT embryos exhibit a
singular, deep invagination of the posterior prechordal floor at E10.5 (Fig. 1A and D). The
mammillary pouch of Sox2HYP embryos, however, is often bifurcated by a region of ectopic
tissue (Fig. 1A, D vs. B and E, arrow). Unlike E10.5 Sox2CONT embryos, a subset of age-
matched Sox2HYP embryos exhibit protuberances in the posterior tuberal hypothalamus (Fig.
1D vs. F, arrowhead). These SEM analyses provide the first insight into the effects SOX2
deficiency on the morphological development of the posterior prechordal floor, a tissue that
is affected in SOX2 haploinsufficient humans (Kelberman et al., 2006).
3.3. Shh signaling and hypothalamic patterning are disrupted in the E12.5 Sox2HYP
prechordal floor
E12.5 Sox2HYP embryos were analyzed histologically at the level of the tuberal
hypothalamus, revealing a protuberance along the prechordal floor. Given that GLI3 has
been implicated in human HHs, we examined Gli3 expression in the E12.5 Sox2HYP
hypothalamic anlage (Wallace et al., 2008). In Sox2CONT embryos, Gli3 is not expressed
along the prechordal floor from its caudal limit to approximately 60 lm anterior to the
mammillary pouch; however, Gli3 is expressed rostral to this point (Fig. 2A and C). In
Sox2HYP embryos, however, Gli3 is absent from the prechordal floor along nearly the entire
length of the tuberal hypothalamus (Fig. 2B and D). Gli3 and Shh have been demonstrated
to be mutually antagonistic in several CNS regions, including the developing spinal cord and
telencephalon (Litingtung and Chiang, 2000; Rallu et al., 2002). Consistent with these
previous findings, Shh exhibits a nearly mutually exclusive expression pattern to Gli3 along
the prechordal floor of E12.5 Sox2CONT embryos, i.e., it is expressed only at low levels in
the mammillary region but is downregulated approximately 60 μm anterior to the
mammillary pouch (Fig. 2A and E). In contrast, Shh expression is observed as far as 300 μm
anterior to the mammillary pouch in Sox2HYP embryos (Fig. 2B and F).
To determine the cell identity of the hypothalamic protuberance in Sox2HYP embryos, we
examined the expression of hypothalamic and neural progenitor markers. Examination of the
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expression of the hypothalamic progenitor marker Nkx2.1 revealed that this gene is
expressed anterior to the mammillary region along the prechordal floor in Sox2CONT
embryos but is absent in the protuberance of the prechordal floor observed in Sox2HYP
embryos (Fig. 2G vs. H). We next examined Sox2CONT and Sox2HYP embryos for the
expression of markers that define and maintain neural progenitor identity: N-cadherin and
Sox2 itself (Graham et al., 2003; Zhang et al., 2010). N-cadherin is expressed normally
along the prechordal floor of Sox2HYP embryos, indicating that these cells have maintained a
neural progenitor identity (Fig. 2I vs. J). Uniform expression of Sox2 is observed along the
prechordal floor of Sox2CONT embryos (Fig. 2K). Sox2 expression is also present throughout
most of the neuroepithelium of Sox2HYP embryos but is nearly undetectable along the
prechordal floor of the tuberal hypothalamus (Fig. 2K vs. L). At E14.5, the protuberance in
the Sox2HYP tuberal hypothalamus remains the same size as at E12.5; however, the Nkx2.1
and Shh expression patterns are unaffected (Fig. S4B and D). These analyses indicate that
morphological defects observed in the prechordal floor of Sox2HYP embryos are associated
with disrupted Shh signaling and abnormal hypothalamic patterning.
3.4. The retinal primordium of E10.5 Sox2HYP embryos is morphologically abnormal
To determine the onset of the optic malformations observed in Sox2HYP mice, we performed
whole-mount and/or SEM analyses of embryos between E9.5 and E14.5. At E9.5, no clear
differences can be discerned between the optic vesicles of whole mount Sox2CONT and
Sox2HYP embryos (Fig. S2A–C). Sox2HYP embryos first exhibit readily discernable
morphological defects at E10.5, during formation of the OC. In Sox2-EGFP/+ embryos, the
EGFP reporter permits visualization of the neural retina as a ring of tissue surrounding the
circular, SOX2-positive invaginating lens (Fig. 3A). In Sox2HYP embryos, however, the
ventral aspect of the retina cannot be discerned through the surface ectoderm (Fig. 3D). By
E13.5 Sox2HYP embryos exhibit coloboma, a persistence of the ventral optic fissure (Fig. 3B
vs. E). Severely affected Sox2HYP embryos develop anophthalmia by E14.5, with only
pigmented epithelial cells remaining (Fig. 3C vs. F).
To determine the nature of the ventral OC defects observed in whole mount E10.5 Sox2HYP
embryos, we performed SEM analysis of the optic anlage. In Sox2CONT embryos, the ventral
aspect of the OC is in close opposition to the surface ectoderm (Fig. 4A and D). Sox2HYP
OCs, however, often exhibit an abnormal morphology, such that there is an increased
separation between the ventral OC and the surface ectoderm (Fig. 4A, D vs. B, C, E and F),
explaining why the ventral OC cannot be discerned through the surface ectoderm in Sox2HYP
embryos (Fig. 3B).
Given that E14.5 and later-stage Sox2HYP embryos exhibit microphthalmia or anophthalmia,
we analyzed cell number, proliferation and apoptosis in E9.5 and E10.5 retinal progenitors
using Hoechst, phospho-histone H3 (PH3), and cleaved caspase-3, respectively. We find that
cell number, proliferation, and apoptosis are not significantly affected in the presumptive
retina of E9.5 or E10.5 Sox2HYP embryos (Fig. S5A–M).
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3.5. Sox2HYP ventral optic stalks are shorter and exhibit increased cell death
We hypothesized that increased separation between the ventral aspect of the Sox2HYP OC
and the surface ectoderm results from a hypoplastic ventral optic stalk; i.e., a decrease in the
length of the ventral optic stalk could prevent the ventral aspect of the OC from reaching the
surface ectoderm. To test this hypothesis, we measured the length of the ventral optic stalk,
identifying a clear trend that, relative to the width of the head, the E10.5 optic stalk is
shorter in Sox2HYP than in age-matched Sox2CONT embryos at the level of the mid OC (Fig.
5E, p = 0.06).
To determine whether the observed shortening of the ventral optic stalk is the result of
increased cell death, cleaved caspase-3 staining was analyzed in E9.5 and E10.5 optic stalks.
At E9.5, both Sox2CONT and Sox2HYP embryos exhibit cell death in the central portion of the
ventral optic stalk, but no statistically significant difference was observed between
Sox2CONT and Sox2HYP embryos (Fig. S5 G–M). At E10.5, however, cell death is rarely
observed in the ventral optic stalk of Sox2CONT embryos, whereas cleaved caspase-3-
positive cells are common in this tissue in Sox2HYP embryos (Fig. 5A, C vs. B and D).
Regions of cell death in E10.5 Sox2HYP ventral optic stalks occasionally result in a
“pinched” appearance, which is never observed in the ventral optic stalk of Sox2CONT
embryos (Fig. 5C vs. D [arrow]). These findings are the first to characterize the early optic
phenotype in mice with reduced SOX2 signaling and support a differential role for SOX2 in
the development of the retinal primordium and the ventral optic stalk. Moreover, these
results are the first to define a requirement for SOX2 in the development of the mammalian
optic stalk.
3.6. Characterization of the patterning of Sox2HYP neural retinas at two developmental
stages
Given that many animal models of ocular defects exhibit abnormal molecular patterning of
the retina and/or optic stalk, we next determined whether molecular patterning was disrupted
in the E10.5 Sox2HYP optic anlage. We examined the expression of proximal/ventral markers
(Pax2, Vax2), which label the ventral optic stalk and ventral retina, the dorsal retina marker
Tbx3, and a marker of the ciliary margin and retinal pigmented epithelium (RPE) (Otx1)
(Nornes et al., 1990; Barbieri et al., 1999; Martinez-Morales et al., 2001; Sowden et al.,
2001). The expression of Pax6, which is present in the retina in a high-distal/low-proximal
gradient, and Rax, which marks all retinal progenitors at this stage, were also examined
(Mathers et al., 1997; Bäumer et al., 2002: Matsushima et al., 2011). In the dorsal and
ventral OC of Sox2HYP embryos, Tbx3 (Fig. 6A and B) and Vax2 (Fig. 6C and D),
respectively, mimic the expression patterns observed in Sox2CONT embryos. Within the
Sox2HYP OC, Pax6 expression is increased (Fig. 6E and F) and Rax expression is largely
unaffected (Fig. 6G and H). Given that (i) Pax2 is associated with coloboma in humans and
mice and (ii) PAX6 and PAX2 are mutually antagonistic in the developing retina, we
examined the expression of Pax2 in Sox2CONT and Sox2HYP embryos (Sanyanusin et al.,
1995; Torres et al., 1996; Schwarz et al., 2000). Whereas Pax2 is strongly expressed in the
ventral OC of Sox2CONT embryos, it is strongly downregulated in the Sox2HYP OC (Fig. 6I
and J). To determine whether the ciliary margin and RPE are correctly specified in Sox2HYP
embryos, we examined the expression of Otx1, which is normally expressed in the distal
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ciliary margin and the RPE. In Sox2CONT embryos at E10.5, Otx1 expression is restricted to
the distal retina and the RPE (Fig. 6K). In E10.5 Sox2HYP OCs, Otx1 expression is normal in
the RPE but is expanded into the central neural retina (Fig. 6L).
To determine the fate of the distalized, Otx1-expressing cell population observed in E10.5
Sox2HYP OCs, we examined marker expression in the E16.5 neural retina and ciliary margin.
In Sox2CONT eyes at E16.5, the neural progenitor marker Notch1 is expressed in the
neuroblast layer of the central retina but is excluded from the ciliary margin (Fig. 7A and B)
(de la Pompa et al., 1997). In Sox2HYP eyes, however, a greater extent of the distal retina is
Notch1-negative (Fig. 7C and D). Instead, this tissue is positive for the ciliary margin
marker Otx1 and exhibits an epithelial morphology that is consistent with a ciliary margin
identity (Fig. 7E, F vs. G and H).
These molecular data suggest that the Sox2HYP retinal primordium is patterned normally at
E10.5, but that (i) Pax6 expression is expanded at the expense of Pax2; and (ii) at both
E10.5 and E16.5, cells in the distal retina have transitioned from a neural to a ciliary margin
identity.
4. Discussion
Here, we present the first analyses of early hypothalamic and ocular development in a mouse
model of human SOX2 haploinsufficiency, a genetic disorder characterized by severe
diencephalic and ocular defects. These findings indicate that SOX2 is required for the proper
morphogenesis and molecular patterning of the posterior prechordal plate, optic stalk and
OC. Furthermore, these results (i) define the morphological and temporal onset of the
defects observed in Sox2HYP embryos, and (ii) identify Shh signaling as a potential mediator
of these abnormalities.
In humans, SOX2 haploinsufficiency causes abnormalities in several brain regions, including
the hypothalamus, optic nerve, and eyes (Kelberman et al., 2006). The nature and timing of
the onset of these defects are unknown, as are the downstream pathways that are involved in
mediating their development. We generated Sox2HYP embryos to directly address these
questions, and thereby identified novel functions for SOX2 in the morphogenesis and
molecular patterning of the diencephalon and the eye. The generation and detailed molecular
analysis of Sox2HYP embryos provide an understanding of the molecular nature and temporal
onset of the defects observed in SOX2 haploinsufficient humans.
Hypothalamic hamartomas are benign overgrowths of the ventral hypothalamus and are
associated with a variety of developmental problems, cognitive deficiencies, and seizures
(Freeman, 2003). In this study, we used SEM to obtain three-dimensional, high-resolution
images of the Sox2HYP hypothalamus, and observed that E10.5 Sox2HYP embryos exhibit a
broad diencephalic prechordal floor from the mammillary area to the infundibulum. This
region encompasses the tuberal region of the hypothalamus, which is associated with HHs in
humans (Booth et al., 2004; Schneider et al., 2009). In E12.5 Sox2HYP embryos, this
expansion manifests as a protuberance into the lumen of the neural tube. The morphogen
Shh acts as a powerful patterning agent along the length of the mouse neural tube, including
the hypothalamus (Briscoe et al., 1999; Szabó et al., 2009). However, in contrast to much of
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the ventral midline, Shh expression is normally excluded from the posterior prechordal floor
(Shimamura et al., 1995). Gli3, a member of the Gli family of transcription factors, has been
demonstrated in several contexts to antagonize Shh signaling; a loss of Gli3 in mouse leads
to an upregulation of Shh in the developing spinal cord (Ruiz i Altaba, 1998), and Shh and
Gli3 have been shown to be functionally antagonistic in the mouse forebrain (Rallu et al.,
2002). Consistent with these findings, Gli3 is normally expressed in the Shh-negative
hypothalamic prechordal floor, and a loss of GLI3 expression in humans has been shown to
result in HH. Molecular analysis of the protuberance observed in Sox2HYP embryos indicates
that the cells at its apex ectopically express Shh and abnormally downregulate Gli3. These
results raise the intriguing possibility that the hypothalamic defects that are observed in
SOX2 haploinsufficient humans result from a dysregulation of Shh signaling. Sox2HYP
embryos recover normal molecular patterning in the hypothalamus by late gestational stages,
consistent with the observation that Gli3-deficient mice, despite exhibiting nearly all of the
defects that are associated with human GLI3 mutations, are not reported to exhibit HH (Böse
et al., 2002). These data suggest a murine-specific compensatory mechanism in the
hypothalamus. Our results also address the question of why the ventral hypothalamus is
more severely affected by SOX2 deficiency than are other regions of the diencephalon. We
find that that Sox2 expression is nearly eliminated in the prechordal floor of Sox2HYP
embryos, which may reflect Sox2 autoregulation and explain the apparent hypersensitivity of
this tissue to SOX2 deficiency. Consistent with this interpretation, evidence for SOX2
autoregulation has been observed in mouse and chick neural stems cells (Miyagi et al., 2004:
Miyagi et al., 2006).
Ocular defects are by far the most commonly described phenotypes in SOX2
haploinsufficient humans and range from coloboma to bilateral anophthalmia (Ragge et al.,
2005; Wang et al., 2008; Schneider et al., 2009). However, there is currently no description
of the effects of germline Sox2 deficiency on oculogenesis earlier than E13.5 in mouse, by
which point mature retinal morphology has been established. Specifically, it is unknown
what role SOX2 plays in the development of the OC or the optic stalk. We report that the
ventral OCs of E10.5 Sox2HYP embryos are abnormally separated from the surface ectoderm
but do not exhibit decreased cell number or proliferation or increased cell death. These data
suggest that a hypoplastic ventral optic stalk leads to abnormal OC morphology. Indeed, we
find that Sox2HYP optic stalks are shorter and exhibit increased cell death. These results are
the first to define a role for SOX2 in optic stalk morphogenesis and indicate that germline
Sox2 deficiency can disrupt OC morphogenesis by causing optic stalk hypoplasia.
The role of SOX2 in the maintenance of neural competency is well established, although it
is unknown how germline Sox2 hypomorphism affects early retinal development (i.e., prior
to E13.5) (Avilion et al., 2003; Favaro et al., 2009). Recent work from our laboratory
demonstrated that conditional ablation of Sox2 from the neural retina at E10.5 using the
Pax6α enhancer-driven Cre results in the conversion of the retinal neuroepithelium to non-
neural ciliary epithelium (Marquardt et al., 2001; Taranova et al., 2006; Matsushima et al.,
2011). These data also demonstrate that SOX2 and PAX6 are mutually antagonistic in the
retina, respectively promoting neural and ciliary fates. Distal (i.e., ciliary) identity is
indicated by Otx1 expression and high expression levels of Pax6 (Martinez-Morales et al.,
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2001; Matsushima et al., 2011). We demonstrate that although overall patterning of the
neural retina is maintained at E10.5, the expression of Otx1 is centrally expanded, and Pax6
is upregulated in the Sox2HYP retina at this stage. These results indicate that retinal neural
progenitors exhibit the first molecular indications of a loss of neuronal competency at E10.5
in the absence of the full complement of SOX2 dosage, defining a temporal requirement for
SOX2 in the establishment of neural fate in the mouse OC. Consistent with the results of the
E10.5 expression analyses, E16.5 Sox2HYP eyes lack expression of the neural progenitor
marker Notch1 in the distal retina. Instead, this region expresses Otx1 and exhibits an
epithelial morphology consistent with a ciliary margin identity. The ciliary fate transition
that is observed in Sox2HYP retinas is intriguing in that it suggests a mechanism by which
microphthalmia develops, i.e., the expansion of the more slowly proliferating, non-neural,
ciliary epithelium would be expected to result in a smaller retina; however, this hypothesis
will have to be directly addressed.
Coloboma is a ventral eye deformity that frequently afflicts human carriers of SOX2
mutations but which has not been described in a mouse model of SOX2 deficiency
(Schneider et al., 2009). PAX2 is also associated with coloboma in humans and mouse, and
its expression is strongly downregulated in the ventral Sox2HYP OC (Sanyanusin et al., 1995;
Torres et al., 1996), suggesting a mechanism by which SOX2 deficiency results in
coloboma.
The question naturally arises of why certain regions of the neuroepithelium are more
severely affected by SOX2 deficiency than others. One possible explanation involves the
other SOXB1 family members, SOX1 and SOX3, which are also broadly expressed in the
developing neural tube, where their functions are thought to be partially redundant (Wood
and Episkopou, 1999; Bylund et al., 2003; Graham et al., 2003). However, SOX1 and SOX3
are not expressed in the neural retina following OC invagination, and SOX1 is excluded
from the ventral midline (Kamachi et al., 1998; Aubert et al., 2003). Given that these two
tissues are the most severely affected in Sox2HYP embryos, these expression profiles fit a
model in which (i) a certain degree of SOXB1 dosage is required in all regions of the neural
epithelium; and (ii) the neural retina and the ventral midline are the most sensitive tissues to
SOX2-deficiency. The phenotypes of SOX3 and SOX1-deficient mice are consistent with
this hypothesis (Malas et al., 2003; Rizzoti et al., 2004; Donner et al., 2007).
In summary, this is the first study to describe early diencephalic and optic development in a
mouse model of human SOX2 haploinsufficiency. Our results demonstrate that SOX2 is
required for proper formation and patterning of the prechordal floor, optic stalk, and the OC.
All of the phenotypes of Sox2HYP embryos recapitulate those described in SOX2
haploinsufficient humans. Furthermore, this work provides significant insights into the
temporal and molecular requirements for SOX2 in the morphogenesis and patterning of the
mammalian CNS.
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Scanning electron analyses of the posterior ventral diencephalon in E10.5 Sox2CONT and
Sox2HYP embryos. (A–C) Posterior-facing views of Sox2CONT (A) and Sox2HYP (B and C)
E10.5 diencephala. Scale bars for A–C: 100 μm. (D–F) Magnified images of the regions
outlined in blue in (A-C) showing the mammillary region, tuberal hypothalamus, and
infundibulum of Sox2CONT (D) and Sox2HYP (E and F) embryos. Sox2CONT mammillary
pouches appear as singular midline invaginations. (D) In contrast, Sox2HYP mammillary
pouches are often divided by ectopic, undescended tissue (arrow in E). The infundibula of
Sox2HYP embryos are expanded relative to those of Sox2CONT embryos (D vs. E, F, red
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asterisks). A subset of Sox2HYP embryos exhibit a protuberance in the tuberal hypothalamus
by E10.5 (arrowhead). Scale bars for D–F: 50 μm. MP: mammillary pouch; TH: tuberal
hypothalamus; I: infundibulum.
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Disrupted Shh signaling and hypothalamic patterning in E12.5 Sox2HYP embryos. (A and B)
Diagram illustrating Shh and Gli3 expression in Sox2CONT (A) and Sox2HYP (B) embryos.
The yellow lines indicate the approximate levels of the cuts in C– L. (C and D) The Shh
signaling antagonist Gli3 is expressed in the prechordal floor of Sox2CONT (C) embryos
between the mammillary region and the infundibulum, but is downregulated in this region in
Sox2HYP (D) embryos. (E and F) Shh expression in the prechordal plate of Sox2CONT (E)
and Sox2HYP (F) embryos. Shh is normally excluded fromthe prechordal floor between the
mammillary region and the infundibulum (E), but remains expressed in this region in
Sox2HYP embryos (F). (G and H) Nkx2.1 is normally expressed throughout the ventral
hypothalamus (G) but is excluded from the prechordal floor in Sox2HYP (H) embryos. (I and
J) N-cadherin is normally expressed in all neural progenitors (I), and this expression pattern
is largely maintained in Sox2HYP (J) embryos. (K and L) Sox2 is also expressed in all neural
progenitors in Sox2CONT (K) embryos, but is strongly downregulated in the prechordal floor
of Sox2HYP (L, arrowhead) embryos. A clear protuberance is present in most Sox2HYP
embryos (13/15 examined).
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Temporal sequence of the ocular phenotype in whole-mount Sox2HYP embryos. (A and D)
Lateral views of E10.5 whole mount Sox2EGFP/+ (A) and Sox2HYP (D) heads. In Sox2EGFP/+
embryos, the ring of the distal optic cup (OC) can be seen ventral and posterior to the
telencephalic vesicle (T), contacting the surface ectoderm. The SOX2-positive lens is visible
in the center of the ring. In contrast, the ventral aspect of the distal OC is not visible in the
Sox2HYP embryo (red arrow, D). (B and E) Lateral views of E13.5 whole mount Sox2EGFP/+
(B) and Sox2HYP (E) eyes. In the Sox2EGFP/+ embryo, the black retinal pigment epithelium
surrounds the entire outer surface of the eye. In contrast, the ventral optic fissure of the
Sox2HYP eye has failed to close, a defect referred to as coloboma (red arrowhead, E). (C and
F) E14.5 whole mount Sox2CONT (C) and Sox2HYP (F) embryos. A round, symmetric eye
with a visible lens is present in the Sox2CONT embryo, whereas only a remnant of the retinal
pigmented epithelium can be seen in the Sox2HYP embryo.
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Scanning electron analyses of the optic anlage of E10.5 Sox2CONTand Sox2HYP embryos. (A
and D) Low- (A) and high- (D) magnification views of an E10.5 Sox2CONT OC. The distal
OC is in close contact with the surface ectoderm, with a slight ventral separation (yellow
line). B, C, E and F) Low- (B and C) and high- (E and F) magnification views of E10.5
Sox2HYP OCs. The distance between the ventral OC and the surface ectoderm is increased in
Sox2HYP embryos (yellow lines in E–F). Scale bars: 100 μm. L: lens, OC: optic cup, SE:
surface ectoderm.
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Morphological and cell death analyses in the ventral optic stalk of E10.5 Sox2CONT and
Sox2HYP embryos. (A and B) Sox2CONT (A) and Sox2HYP (B) optic stalks stained for
cleaved caspase-3. Positively stained cells are more common in Sox2HYP optic stalks (arrow
in D). Red staining on the dorsal surface of the optic stalk does was not associated with
nuclei and was not included in the analysis. (C and D) Magnified images of the regions
outlined in (A) and (B), respectively. (E) Quantification of optic stalk length (optic stalk
length/head width = 0.504 ± 0.004 and 0.492 ± 0.004 for Sox2CONT and Sox2HYP optic
stalks, respectively, p = 0.06, n = 11 optic stalks for both groups). D: distal, P: proximal.
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In situ analyses of patterning markers in E10.5 Sox2CONT and Sox2HYP embryos. (A–D) The
expression of the dorsal/ventral patterning markers Tbx3 (A and B) and Vax2 (C and D) are
unaffected in Sox2HYP embryos. Pax6 (E and F) expression is upregulated in Sox2HYP OCs
(arrow F). (G and H) The expression of the retinal progenitor marker Rax is observed in all
neural progenitors of the central retina in both Sox2CONT (G) and Sox2HYP (H) OCs. (I and
J) Pax2 is expressed throughout the ventral retina in Sox2CONT embryos (I) but is strongly
downregulated in the Sox2HYP OC (J, arrow). The expression of the early ciliary margin
marker Otx1 is observed in the retinal pigmented epithelium and distal retina in Sox2CONT
embryos (K) but is expanded centrally in Sox2HYP OCs (L, brackets). A minimum of n = 3
Sox2CONT and Sox2HYP embryos were analyzed for each in situ probe.
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In situ analyses of Notch1 and Otx1 expression in E16.5 Sox2CONT and Sox2HYP eyes. (A–
D) Notch1 expression in E16.5 Sox2CONT (A and B) and Sox2HYP (C and D) eyes. Notch1
expression is notably absent from a wide portion of the distal retina in Sox2HYP eyes. (B)
and (D) are magnified images of the indicated areas in (A) and (C), respectively. (E–H) Otx1
expression in E16.5 Sox2CONT (I) and Sox2HYP (K) eyes. Otx1 expression is expanded in
Sox2HYP eyes. (F) and (H) are magnified images of the indicated areas in (E) and (G),
respectively. D: dorsal, V: ventral.
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